Cite
MLA Citation
Andrew Lotery et al.. “Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.” Lancet, vol. 395, no. 10220, 2019, pp. 294–303. http://access.bl.uk/ark:/81055/vdc_100099354041.0x000059